Montana Asbestos Clinic Faces New Legal Battle Over Alleged Malpractice and Misdiagnosis, Linking Opioid Prescriptions to Wrongful Death Claims

LIBBY, Mont. – A local clinic reputed for treating asbestos-related diseases is again in the legal crosshairs, this time facing allegations of medical malpractice and wrongful death connected to opiate prescriptions and misdiagnoses. A lawsuit filed October 10 in Lincoln County District Court accuses Dr. Charles Brad Black, the Center for Asbestos Related Disease, and other associated medical personnel of serious errors in diagnosis and medication practices that purportedly led to disability and death among residents. The complaint, lodged by Thomas Steiger, a representative of the late Terry L. Steiger who died in 2015, and … Read more

Law Firm Turns Opioid Case Fees Into Securities for Investors, Shifting Legal Landscape

In a bold move that blurs the lines between legal practice and financial innovation, a New York-based law firm is transforming its future legal fees from opioid litigation into securities for investment. Napoli Shkolnik PLLC, a prominent player in mass tort litigation, has packaged its anticipated earnings from approximately $1.3 billion in settlements with opioid manufacturers and pharmacies—including giants like McKesson, Janssen, CVS, and Walgreens—into a new financial product. These settlements, detailed in a Securities and Exchange Commission filing, mark the company’s strategy to monetize anticipated profits upfront. This approach reflects a growing trend where … Read more

Supreme Court Set to Deliver Landmark Verdict on Purdue Pharma Bankruptcy Amid Opioid Epidemic

Washington, D.C. – A pivotal decision is expected from the U.S. Supreme Court regarding the bankruptcy case of Purdue Pharma LP, as the nation continues grappling with an opioid crisis that has claimed over 750,000 lives to date. This ruling could herald a significant development in addressing the ramifications of one of the deadliest health emergencies in American history. Purdue Pharma, the maker of OxyContin, has been at the epicenter of lawsuits and public outcry, with numerous claims that the company aggressively marketed its highly addictive painkiller without proper warnings of its potential for abuse. … Read more

Flint Cooper’s Alex Parker Takes on Key Role in Opioid Crisis Legal Battle, Joins Leadership Team in Suboxone Litigation

Flint, MI – Alex Parker, a seasoned attorney at Flint Cooper, has been appointed to the Leadership Development Committee in the multifaceted Suboxone multidistrict litigation. This prominent role underscores Parker’s reputation in the legal community and highlights the significant responsibilities and influence that such positions entail. Parker’s appointment is a strategic move in the litigation that involves numerous cases related to the opioid treatment drug, Suboxone. These cases have been consolidated due to their shared legal questions concerning the drug’s marketing and safety practices. By taking on this pivotal role, Parker not only represents Flint … Read more